Benmoxine

Title: Benmoxine
CAS Registry Number: 7654-03-7
CAS Name: Benzoic acid 2-(1-phenylethyl)hydrazide
Additional Names: 1-(benzoyl)-2-(a-methylbenzyl)hydrazine; 1-(a-methylbenzyl)-2-benzoylhydrazine
Trademarks: Neuralex (Millot)
Molecular Formula: C15H16N2O
Molecular Weight: 240.30
Percent Composition: C 74.97%, H 6.71%, N 11.66%, O 6.66%
Literature References: Prepn: Bettinetti, Farmaco Ed. Sci. 16, 823 (1961); FR 1314362 (1963 to I.C.I.), C.A. 59, 2716a (1963), corresp to GB 919491.
Properties: Crystals from isopropyl ether or petr ether + benzene, mp 93-94°.
Melting point: mp 93-94°
Therap-Cat: Antidepressant.
Keywords: Antidepressant; Hydrazides/Hydrazines.
Status: This monograph has been retired and is no longer subject to revision or update.
Benorylate Benoxacor Benoxaprofen Benoxinate Benperidol

Benmoxin
Benmoxin skeletal.svg
Systematic (IUPAC) name
N-(1-phenylethyl)benzohydrazide
Clinical data
Legal status Prescription only
Routes Oral
Identifiers
CAS number 7654-03-7 N
ATC code None
PubChem CID 71671
ChemSpider 64728 YesY
UNII XC9FY2SGBG YesY
Chemical data
Formula C15H16N2O 
Mol. mass 240.30 g/mol
 N (what is this?)  (verify)

Benmoxin (trade names Neuralex, Nerusil), also known as mebamoxine, is an irreversible and nonselective monoamine oxidase inhibitor (MAOI) of the hydrazine class.[1][2] It was synthesized in 1967 and was subsequently used as an antidepressant in Europe, but is now no longer marketed.[1][2]